loading
Thermo Fisher Scientific Inc stock is traded at $568.53, with a volume of 493.68K. It is up +1.98% in the last 24 hours and up +23.07% over the past month. Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$557.63
Open:
$558.31
24h Volume:
493.68K
Relative Volume:
0.23
Market Cap:
$214.56B
Revenue:
$43.74B
Net Income/Loss:
$6.59B
P/E Ratio:
32.86
EPS:
17.3021
Net Cash Flow:
$6.11B
1W Performance:
+0.26%
1M Performance:
+23.07%
6M Performance:
+33.01%
1Y Performance:
+3.81%
1-Day Range:
Value
$555.06
$568.66
1-Week Range:
Value
$555.06
$578.24
52-Week Range:
Value
$385.46
$610.97

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Name
Name
Thermo Fisher Scientific Inc
Name
Phone
(781) 622-1000
Name
Address
168 THIRD AVENUE, WALTHAM, MA
Name
Employee
125,000
Name
Twitter
@thermofisher
Name
Next Earnings Date
2025-10-22
Name
Latest SEC Filings
Name
TMO's Discussions on Twitter

Compare TMO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
568.20 210.57B 43.74B 6.59B 6.11B 17.30
Diagnostics & Research icon
DHR
Danaher Corp
217.81 153.21B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
630.39 50.75B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
145.27 41.35B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
221.10 37.15B 15.70B 1.24B 2.01B 6.9036

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-11-25 Upgrade Barclays Equal Weight → Overweight
Aug-19-25 Initiated William Blair Outperform
Jul-24-25 Downgrade HSBC Securities Buy → Hold
Jul-11-25 Upgrade Scotiabank Sector Perform → Sector Outperform
Jul-09-25 Downgrade UBS Buy → Neutral
Jan-10-25 Upgrade Bernstein Mkt Perform → Outperform
Dec-23-24 Initiated Scotiabank Sector Perform
Oct-14-24 Initiated Redburn Atlantic Buy
Oct-01-24 Initiated Stephens Overweight
Aug-28-24 Initiated Wells Fargo Overweight
Jun-03-24 Resumed Jefferies Buy
Mar-18-24 Resumed Citigroup Neutral
Jan-24-24 Downgrade Barclays Overweight → Equal Weight
Jan-08-24 Downgrade Bernstein Outperform → Mkt Perform
Dec-18-23 Initiated HSBC Securities Buy
Dec-13-23 Initiated Wolfe Research Outperform
Oct-26-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-25-23 Upgrade Wells Fargo Underweight → Equal Weight
Sep-28-23 Initiated Bernstein Outperform
Sep-06-23 Resumed Citigroup Buy
Jul-19-23 Initiated Raymond James Outperform
Jul-19-23 Reiterated Robert W. Baird Outperform
Jul-13-23 Upgrade Credit Suisse Neutral → Outperform
Apr-04-23 Reiterated Barclays Overweight
Dec-14-22 Initiated Deutsche Bank Buy
Dec-07-22 Initiated RBC Capital Mkts Outperform
Oct-27-22 Downgrade The Benchmark Company Buy → Hold
Aug-25-22 Initiated Credit Suisse Neutral
Apr-25-22 Downgrade Wells Fargo Equal Weight → Underweight
Jan-26-22 Resumed Barclays Overweight
Oct-20-21 Upgrade Citigroup Neutral → Buy
Oct-15-21 Resumed Cowen Outperform
Aug-05-21 Resumed Credit Suisse Outperform
Jul-16-21 Initiated The Benchmark Company Buy
Mar-18-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21 Initiated Barclays Overweight
Jan-08-21 Upgrade Credit Suisse Neutral → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-02-20 Initiated Goldman Buy
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Sep-30-20 Initiated Atlantic Equities Overweight
Sep-14-20 Initiated Morgan Stanley Overweight
Aug-20-20 Resumed JP Morgan Overweight
Jul-15-20 Upgrade Cleveland Research Neutral → Buy
Jul-07-20 Reiterated Needham Buy
Apr-23-20 Reiterated Needham Buy
Jan-31-20 Reiterated Needham Buy
Jan-22-20 Initiated Credit Suisse Neutral
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Initiated Stifel Buy
Jul-25-19 Reiterated Needham Buy
Jul-16-19 Downgrade Needham Strong Buy → Buy
May-30-19 Initiated Wolfe Research Outperform
May-23-19 Reiterated Needham Strong Buy
Apr-22-19 Reiterated Needham Strong Buy
Apr-16-19 Reiterated BofA/Merrill Buy
View All

Thermo Fisher Scientific Inc Stock (TMO) Latest News

pulisher
11:52 AM

Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive

11:52 AM
pulisher
11:36 AM

Thermo Fisher Scientific to Acquire Clario Holdings For $8.875 Billion - citybiz

11:36 AM
pulisher
11:21 AM

Thermo Fisher to buy Clario for $8.8bn - Yahoo Finance

11:21 AM
pulisher
11:21 AM

Thermo Fisher Scientific to acquire Clario in $8.9B cash deal - Proactive financial news

11:21 AM
pulisher
11:10 AM

Argus Research Adjusts Thermo Fisher Scientific Price Target to $610 From $580 - MarketScreener

11:10 AM
pulisher
10:08 AM

Thermo Fisher to Acquire Clario for $8.875 Billion - Contract Pharma

10:08 AM
pulisher
09:42 AM

Thermo Fisher Scientific, U.S clinical research major, invests ₹160 cr in Bengaluru for antibody research - The Hindu

09:42 AM
pulisher
09:00 AM

Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034 - GlobeNewswire Inc.

09:00 AM
pulisher
08:43 AM

Thermo Fisher to buy Clario Holdings for $8.88B - Axios

08:43 AM
pulisher
08:30 AM

If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now - Nasdaq

08:30 AM
pulisher
08:24 AM

Thermo Fisher strikes $9.4bn acquisition of Nordic Capital and Astorg-backed Clario - Private Equity Insights

08:24 AM
pulisher
08:16 AM

Does Thermo Fisher's 20% Rally Signal More Upside After New Pharma Partnerships? - Yahoo Finance

08:16 AM
pulisher
08:01 AM

Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters

08:01 AM
pulisher
07:40 AM

Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal - Asianet Newsable

07:40 AM
pulisher
07:37 AM

Thermo Fisher Scientific Inc. agreed to acquire Clario Holdings, Inc. for $9.4 bilion. - MarketScreener

07:37 AM
pulisher
07:24 AM

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - BioSpace

07:24 AM
pulisher
06:53 AM

Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - The Wall Street Journal

06:53 AM
pulisher
06:51 AM

WilmerHale Advises Thermo Fisher Scientific on $9 Billion Acquisition of Clario - WilmerHale

06:51 AM
pulisher
06:35 AM

Thermo Fisher Announces Acquisition of Clario Holdings - TipRanks

06:35 AM
pulisher
06:30 AM

Media: Thermo Fisher close to USD 10bn acquisition - medwatch.com

06:30 AM
pulisher
06:10 AM

Thermo Fisher to Buy Clinical Services Provider Clario for up to $9.4 Billion - US News Money

06:10 AM
pulisher
06:09 AM

Thermo Fisher Scientific to acquire Clario Holdings, enabling pharma and biotech customers to accelerate innovation with deeper clinical insights - MarketScreener

06:09 AM
pulisher
06:09 AM

PE investor group to sell clinical trial data firm Clario to Thermo Fisher Scientific for $8.9bn - pehub.com

06:09 AM
pulisher
06:03 AM

Thermo Fisher Scientific To Acquire Clario Holdings, Enabling Pharma And Biotech Customers To Accelerate Innovation With Deeper Clinical Insights - TradingView

06:03 AM
pulisher
06:00 AM

Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru - Medical Dialogues

06:00 AM
pulisher
04:58 AM

Research Antibodies Market to Get an Explosive Growth | Thermo - openPR.com

04:58 AM
pulisher
03:58 AM

Thermo Fisher Scientific Expands Bengaluru R&D Center with INR 160 Cr Investment - Digital Health News

03:58 AM
pulisher
02:50 AM

M&A News: Thermo Fisher (TMO) Nears $10B Clario Takeover to Strengthen Clinical Trial Tech - TipRanks

02:50 AM
pulisher
02:48 AM

Thermo Fisher said to eye $10B takeover of clinical trial software firm Clario - Seeking Alpha

02:48 AM
pulisher
02:13 AM

Thermo Fisher Scientific to accelerate life science breakthroughs with OpenAI - SelectScience

02:13 AM
pulisher
01:38 AM

5 Revealing Analyst Questions From Thermo Fisher’s Q3 Earnings Call - Yahoo! Finance UK

01:38 AM
pulisher
Oct 28, 2025

Thermo Fisher Scientific inaugurates expanded R&D centre of excellence in Bengaluru - ETHRWorld.com

Oct 28, 2025
pulisher
Oct 28, 2025

14-year-old Combines Origami and Physics to Engineer - GlobeNewswire

Oct 28, 2025
pulisher
Oct 28, 2025

14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher nears $10 billion takeover of Clario, FT reports - Reuters

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher nears $10 bln deal to acquire Clario, FT reports - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher nears $10 billion takeover of drug trial software maker ClarioFT - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher strikes up to $9.4bn takeover of drug trial software maker Clario - Financial Times

Oct 28, 2025
pulisher
Oct 28, 2025

Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Can Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit consensus price targetsOil Prices & Daily Stock Trend Watchlist - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher Scientific invests ₹160 cr to expand Bengaluru R&D centre - BusinessLine

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM - The Joplin Globe

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher: Measuring Clinical Supply Chain Emissions - Supply Chain Digital Magazine

Oct 28, 2025
pulisher
Oct 28, 2025

Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $656 From $560, Keeps Overweight Rating - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher invests Rs 160 crore to expand Bengaluru R&D centre - Moneycontrol

Oct 28, 2025
pulisher
Oct 28, 2025

Is Thermo Fisher Scientific’s Stock Rally Justified After Strategic Growth Initiatives in 2025? - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher Enhances India's Biotechnology Landscape with R&D Expansion - Devdiscourse

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher invests ₹160 crore to expand Bengaluru R&D facility, to create 100 jobs - ET HealthWorld

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher Scientific invests Rs. 160 crore, Bengaluru R&D will create over 100 jobs - Pharmabiz.com

Oct 28, 2025
pulisher
Oct 28, 2025

Thermo Fisher Scientific inaugurates expanded R&D Centre of Excellence in Bengaluru - Express Pharma

Oct 28, 2025

Thermo Fisher Scientific Inc Stock (TMO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DHR
$217.76
price up icon 0.40%
$630.39
price down icon 0.53%
diagnostics_research A
$145.27
price down icon 0.37%
diagnostics_research IQV
$221.10
price up icon 1.32%
diagnostics_research MTD
$1,398.20
price down icon 0.21%
Cap:     |  Volume (24h):